Patients' Survival Expectations before Localized Prostate Cancer Treatment by Treatment Status

Abstract
Background: Cancer-specific mortality is projected to be only 1% in 15 years in approximately 75% of patients with screen-detected localized prostate cancer (LPC). Nearly 94% of patients choose treatment even though treatment damages health-related quality of life. No data are available regarding what survival benefit patients expected from treatment.

This publication has 0 references indexed in Scilit: